Brady (NYSE:BRC) reported quarterly earnings of $0.72 per share which missed the analyst consensus estimate of $0.75 by 4 percent. This is a 12.5 percent increase over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $321.48 million which beat the analyst consensus estimate of $313.79 million by 2.45 percent. This is a 15.96 percent increase over sales of $277.23 million the same period last year.
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera’s COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 16)
